on invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Cervix Cancer. - HX4-cervix

MAASTRO Clinic0 个研究点目标入组 20 人开始时间: 2014年3月28日最近更新: 2023年12月19日

试验速览

暂无简介。

•-Histologically confirmed cervix carcinoma (squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma)
•- tumor stages FIGO IB – IVA
•-WHO performance status 0 to 2
•- Scheduled for primary curative radiotherapy (either or not combined with chemotherapy or
•hyperthermia)
•- No previous surgery to the Cervix
•- No previous radiation to the Cervix
•- The patient is willing and capable to comply with study procedures
•- 18 years or older
•-Written informed consent before patient registration
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 10
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 10

•- Recent (< 3 months) myocardial infarction
•- Uncontrolled infectious disease
•- Pregnant or breast feeding and/or not willing to take adequate contraceptive measures during the study

发起方